Virtus LifeSci Biotech Clinical Trials ETF - USD Stock

ETF

BBC

US26923G3011

Delayed Nyse 09:54:53 2024-04-23 am EDT 5-day change 1st Jan Change
25.67 USD +1.97% Intraday chart for Virtus LifeSci Biotech Clinical Trials ETF - USD -2.71% +5.07%
Current month-13.58%
1 month-12.42%
Dynamic Chart

Investment objective

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Name
Price
Change
5d. change
1st Jan change
Weight
40.45 USD +3.37%-4.82%+163.44%2.25%
67.18 USD +1.34%-1.49%-18.59%1.54%
11.6 USD +2.47%-2.60%+42.80%1.53%
7.5 USD +11.11%-18.97%-10.29%1.52%
8.155 USD +2.84%-2.38%+101.23%1.51%
16.14 USD +3.26%-5.46%+60.70%1.50%
25.65 USD +3.14%+5.89%+96.09%1.45%
66.87 USD +4.73%-1.40%+260.02%1.43%
13.39 USD +1.59%-0.81%+11.97%1.43%
56.46 USD +1.22%-1.16%+44.18%1.39%
See all (105)
In partnership with
TrackInsight
Date Price Change Volume
24-04-23 25.67 +1.97% 216
24-04-22 25.17 +1.19% 802
24-04-19 24.88 -1.96% 2,095
24-04-18 25.38 -1.42% 233
24-04-17 25.74 -1.26% 1,431

Delayed Quote Nyse

Last update April 23, 2024 at 09:54 am EDT

More quotes

ETF Ratings

Description

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2014-12-15
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-03-26 )

AuM (EUR) 11 M€
AuM 1M 12 M€
AuM 3 months 10 M€
AuM 6 months 8 M€
AuM 12 months 11 M€